c-MET Antikörper
Kurzübersicht für c-MET Antikörper (ABIN7384422)
Target
Alle c-MET (MET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Affinity Purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:1000-1:2000 IHC 1:20-1:50 IF 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 300 μg/mL
-
Buffer
- 50 mM Tris-Glycine( pH 7.4), 0.15M NaCl, 40 % Glycerol, 0.01 % Sodium azide and 0.05 % BSA
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- c-MET (MET) (Met Proto-Oncogene (MET))
-
Andere Bezeichnung
- c Met
-
Hintergrund
- MET,AUTS9,DFNB97,HGFR,RCCP2,c-Met,The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.
-
Molekulargewicht
-
Observed_MW: 170kDa
Calculated_MW: 156kDa
-
Gen-ID
- 4233
-
UniProt
- P08581
-
Pathways
- RTK Signalweg, Carbohydrate Homeostasis, Synaptic Membrane, Signaling of Hepatocyte Growth Factor Receptor
Target
-